The Honey Stick vs. HRT
Some women take HRT. Some can't. Some won't. We built the Honey Stick for all three.
This is not an alternative-to-HRT page. HRT is the most effective intervention for vasomotor symptoms ever measured, and for the woman within ten years of her last period under sixty, the consensus position of the Menopause Society and the Endocrine Society is that the benefits generally outweigh the risks. We respect that. We are not telling you to choose Bloom instead.
What HRT addresses
Vasomotor symptoms (hot flashes, night sweats). Vaginal atrophy. Bone density preservation in the appropriate cohort.
What Bloom addresses
The brain-branch chemistry: mood, sleep onset, focus, central desire. The slow-burn loops: inflammation, mitochondrial bioenergetics, bone density (cited: Pingali 2022 Phytomedicine, n=60 postmeno, 48 weeks). The signal pathway upstream. The sublingual delivery route.
For the woman who has chosen against HRT
You are not anti-science. You are pro-knowing-what-you-took. The 4-Pathway Method is the OTC architecture built for the woman who has decided to take this on herself. Every dose disclosed. Every ingredient on a cited RCT. A NAMS-certified MD on the formulation.
For the woman who can't take HRT
Hormone-sensitive cancer history. Currently on Tamoxifen, an aromatase inhibitor, Lupron. Read the After Cancer page first and bring it to your oncologist.